7Baggers
Quarterly
Annual
    Unit: USD2023-12-31 2023-09-30 2023-06-30 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 
      
    		                           
      net product revenue
    		19,453,000 7,014,000 1,496,000      10,091,000 12,243,000 10,995,000 14,229,000 17,554,000 16,437,000 19,320,000 19,826,000 29,116,000 33,161,000          
      yoy
    		        -42.51% -25.52% -43.09% -28.23% -39.71% -50.43%              
      qoq
    		177.35% 368.85%       -17.58% 11.35% -22.73% -18.94% 6.80% -14.92% -2.55% -31.91% -12.20%           
      cost of products sold
    		693,000 117,000 36,000      3,285,000 2,457,000 2,414,000 2,823,000 3,622,000 3,266,000 4,292,000 3,120,000 3,512,000 6,592,000          
      gross profit
    		18,760,000 6,897,000 1,460,000                         
      yoy
    		                           
      qoq
    		172.00% 372.40%                          
      gross margin %
    		96.44% 98.33% 97.59%      0% 0% 0% 0% 0% 0% 0% 0% 0% 0%          
      operating expenses:
    		                           
      research and development expenses
    		2,359,000 2,849,000 4,223,000 4,380,000 6,762,000 3,852,000 5,286,000 5,569,000 4,057,000 5,530,000 7,757,000 7,539,000 10,292,000 7,329,000 6,086,000 11,402,000 11,890,000 9,951,000 11,325,000 8,095,000 6,792,000 7,206,000 5,283,750 8,143,000 7,604,000 5,388,000  
      selling, general and administrative expenses
    		41,301,000 39,158,000 46,778,000 21,283,000 15,174,000 11,012,000 8,974,000 8,423,000 7,095,000 7,913,000 7,663,000 5,316,000 6,758,000 10,446,000 23,200,000 24,829,000 27,843,000 24,487,000 23,056,000 11,563,000 12,429,000 11,812,000 8,372,750 12,740,000 11,290,000 9,461,000  
      restructuring income
    		                           
      total operating expense
    		30,326,500 42,007,000 51,001,000 25,663,000  14,811,000 564,750 13,697,000                    
      operating income
    		-24,900,000 -35,110,000 -49,541,000 -25,663,000 -21,936,000 -14,811,000 -14,260,000 -13,697,000 40,269,000 -6,497,000 -7,347,000 -4,147,000 -4,451,000 -8,167,000 -75,421,000 -14,095,000 -2,785,000 -12,625,000 -4,080,000 26,118,000 34,126,000 33,341,000 17,064,000 -16,190,000 -11,543,000 5,542,000  
      yoy
    		13.51% 137.05% 247.41% 87.36% -154.47% 127.97% 94.09% 230.29% -1004.72% -20.45% -90.26% -70.58% 59.82% -35.31% 1748.55% -153.97% -108.16% -137.87% -123.91% -261.32% -395.64% 501.61%      
      qoq
    		-29.08% -29.13% 93.04% 16.99% 48.11% 3.86% 4.11% -134.01% -719.81% -11.57% 77.16% -6.83% -45.50% -89.17% 435.09% 406.10% -77.94% 209.44% -115.62% -23.47% 2.35% 95.39% -205.40% 40.26% -308.28%   
      operating margin %
    		-128.00% -500.57% -3311.56%      399.06% -53.07% -66.82% -29.14% -25.36% -49.69% -390.38% -71.09% -9.57% -38.07%          
      investment and other income
    		-1,632,000 903,000 623,000 489,000 432,000 610,000 74,000 213,000 -741,000 -378,000 -1,479,000 781,000 950,000 817,000 -393,000 208,000 583,000           
      interest expense
    		-2,354,000 -1,978,000 -2,295,000 -1,929,000 -1,930,000 -1,929,000 -3,308,000 -3,259,000 -3,237,000 -3,190,000 -3,190,000 -3,125,000 -3,106,000 -3,062,000 -3,045,000 -3,000,000 -2,980,000 -1,597,000 -263,000 -263,000 -263,000 -263,000 -261,000 -264,000 -263,000 -175,000  
      loss on extinguishment of debt
    		  -13,129,000                         
      income before income taxes
    		-28,886,000 -36,185,000 -64,342,000 -27,103,000 -23,346,000 -16,052,000 -14,130,000 -16,743,000 36,166,000 -10,375,000 -11,736,000 -6,630,000 -6,824,000 -13,392,000 -78,392,000 -16,462,000 -3,780,000 -14,563,000 -5,686,000 27,600,000 36,297,000 34,449,000 18,080,000 -16,543,000 -12,509,000 765,000  
      income tax benefit
    		-100,000 89,000 90,000 -5,101,000  -2,607,000 -2,852,000 -5,040,000 5,292,000 -9,510,000 -8,997,000 2,234,000 1,781,000 -374,000 -14,533,000 -691,000 -342,000 -2,327,000          
      net income
    		-28,786,000 -36,274,000 -64,432,000 -22,002,000 -19,581,000 -13,445,000 -11,278,000 -11,703,000 30,874,000 -865,000 -2,739,000 -8,864,000 -8,605,000 -13,018,000 -63,859,000 -15,771,000 -3,438,000 -12,236,000 -8,245,000 21,679,000 28,927,000 25,910,000 4,734,000 -19,994,000 -19,958,000 -6,376,000  
      yoy
    		47.01% 169.80% 471.31% 88.00% -163.42% 1454.34% 311.76% 32.03% -458.79% -93.36% -95.71% -43.80% 150.29% 6.39% 674.52% -172.75% -111.89% -147.23% -274.17% -208.43% -244.94% -506.37%      
      qoq
    		-20.64% -43.70% 192.85% 12.36% 45.64% 19.21% -3.63% -137.91% -3669.25% -68.42% -69.10% 3.01% -33.90% -79.61% 304.91% 358.73% -71.90% 48.41% -138.03% -25.06% 11.64% 447.32% -123.68% 0.18% 213.02%   
      net income margin %
    		-147.98% -517.17% -4306.95%      305.96% -7.07% -24.91% -62.30% -49.02% -79.20% -330.53% -79.55% -11.81% -36.90%          
      net income per share
    		-0.29 -0.41 -0.83 -0.38 -0.33 -0.23 -0.23 -0.2 0.57 -0.02 -0.07 -0.24 -0.23 -0.35 -1.71 -0.43 -0.09 -0.32 -0.18 0.54 0.7 0.63 -0.28 -0.48 -0.48 -0.15  
      weighted-average number of shares outstanding - basic
    		80,174 89,380 77,246 58,585 58,488 58,443 52,996 58,213 54,272 41,057 37,403 37,436 37,356 37,354 37,325 36,904 36,772 38,559 40,465 40,061 41,091 41,374 41,248 41,241 41,241 41,241  
      weighted-average number of shares outstanding - diluted
    		80,174 89,380 77,246 58,585 58,488 58,443 54,941 58,213 69,942 41,057 37,403 37,436 37,356 37,354 37,325 36,904 36,772 38,559 41,765 41,339 42,487 42,810 41,248 41,241 41,241 41,241  
      restructuring expense
    		                           
      intangible asset amortization
    		        203,000 203,000 206,000 205,000 204,000 201,000 1,623,000 1,620,000 1,609,000 1,767,000 1,967,000 564,000 564,000 564,000 2,970,000 3,702,000 3,702,000 3,514,000  
      changes in fair value of contingent consideration
    		       -69,000 918,000 2,478,000                  
      gain on sale of hospital products
    		                           
      gain from release of certain liabilities
    		    88,000 78,000                      
      other income - changes in fair value of contingent consideration payable
    		        -125,000 -310,000                  
      restructuring costs
    		        24,000 159,000 1,841,000 1,866,000 1,506,000 1,228,000 748,000 65,000 50,000 153,000   1,069,000 2,653,000      
      total operating income
    		    21,936,000    -30,178,000                   
      income tax (benefit) expense
    		    -3,765,000                       
      restructuring (income) costs
    		     -53,000  -226,000           793,250 -549,000        
      loss on deconsolidation of subsidiary
    		          162,000  -167,000 -2,673,000              
      gain on sale of hospital business
    		        -45,760,000                   
      total operating expenses
    		         18,740,000 18,342,000 18,376,000 22,005,000 24,604,000 96,341,000 33,921,000 32,015,000 45,918,000 38,832,000 13,557,000 12,185,000 19,166,000      
      revenues:
    		                           
      license revenue
    		              1,600,000  114,000 132,000          
      total revenues
    		          10,995,000 14,229,000 17,554,000 16,437,000 20,920,000 19,826,000 29,230,000 33,293,000          
      changes in fair value of related party contingent consideration
    		          -1,539,000 627,000 -377,000 2,134,000       -13,230,000 -6,971,000 -3,704,000 20,848,000 23,898,000   
      other income - changes in fair value of related party payable
    		          118,000 -139,000 -50,000 -307,000 467,000 425,000 1,402,000 -395,000 -917,000 768,000 1,670,000 550,000 -413,000 -1,828,000 -2,773,000   
      gain - changes in fair value of related party contingent consideration
    		              -4,259,000 -7,115,000 -12,889,000 2,968,000          
      investment income and other income
    		                 54,000          
      product sales and services
    		                  34,832,000 39,147,000 47,105,000 51,757,000 42,364,000 31,340,000 38,165,000 35,353,000  
      license and research revenue
    		                  -80,000 528,000 -794,000 750,000 721,000 747,000 693,000 863,000  
      total
    		                  34,623,250 39,675,000 46,311,000 52,507,000 43,085,000 32,087,000 38,858,000 36,216,000  
      cost of products and services sold
    		                  4,048,000 3,790,000 4,561,000 3,902,000 2,591,000 2,844,000 3,907,000 4,395,000  
      (gain)/loss - changes in fair value of related party contingent consideration
    		                  -7,526,750 -9,906,000        
      investment income
    		                  161,000 1,110,000 527,000 1,052,000 270,000 490,000 390,000 200,000  
      foreign exchange gain
    		                  -587,000 -133,000 237,000  1,135,000 1,249,000 1,680,000 -2,941,000  
      income tax provision
    		                  2,559,000 5,921,000 7,370,000 8,539,000 4,553,000 3,451,000 7,449,000 7,141,000  
      foreign exchange loss
    		                     -231,000      
      changes in fair value of related party acquisition-related contingent consideration
    		                         7,916,000  
      interest expense - changes in fair value of related party financing-related contingent consideration
    		                         -1,861,000  
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.